Pharma Opportunity Fund

875500H0Q8P01AV37396Copied!

ACTIVE LAPSED FUND 🇱🇮 Liechtenstein

Pharma Opportunity Fund is an active legal entity registered in Liechtenstein (LI). LEI code: 875500H0Q8P01AV37396. The LEI was first issued on Aug 5, 2024 and is managed by LOU 52990034RLKT0WSOAM90. Next renewal is due Aug 6, 2025.

Entity Details

LEI Code 875500H0Q8P01AV37396 Legal Name Pharma Opportunity Fund Status ACTIVE Jurisdiction 🇱🇮 Liechtenstein (LI) Category Investment Funds Legal Form Other / Not Classified Registration #

Registration & Compliance

Reg. Status LAPSED Initial Reg. Aug 5, 2024 Last Updated Aug 6, 2025 Next Renewal Aug 6, 2025 (194 days overdue) Corroboration ENTITY_SUPPLIED_ONLY Managing LOU GS1 AISBL Reg. Authority Other Authority

Addresses

Legal / Registered Address
Industriestrasse 2
c/o CAIAC Fund Management AG
Bendern
LI-03
9487
LI
Headquarters Address
c/o CAIAC Fund Management AG
Industriestrasse 2
Gamprin-Bendern
LI-03
9487
LI

📅 Registration Timeline

First Issued
Aug 5, 2024 — LEI initially registered
Renewal Overdue
Aug 6, 2025 — Renewal deadline has passed
Last Updated
Aug 6, 2025 — Record data last refreshed

Data Quality

60%
6 of 10 data fields populated
Legal Name
Legal Address
HQ Address
Jurisdiction
Registration #
Legal Form
BIC / SWIFT
Ownership Data
Other Names
Corroboration

🔎 LEI Code Anatomy

Every LEI is a 20-character alphanumeric code structured in three parts per ISO 17442

8755
00H0Q8P01AV373
96
LOU Prefix
Characters 1–4 identify the Local Operating Unit that issued this LEI
Entity Identifier
Characters 5–18 are unique to this specific legal entity
Check Digits ✓
Characters 19–20 are verification digits (MOD 97-10). This LEI passes checksum validation.

Ownership & Relationships

Corporate structure and ownership hierarchy based on GLEIF Level 2 relationship data

Parent Entities (2)

CAIAC Fund Management AG is fund-managed by
Brainstone SICAV is subfund of

? Frequently Asked Questions

What is the LEI number for Pharma Opportunity Fund? +

The Legal Entity Identifier (LEI) for Pharma Opportunity Fund is 875500H0Q8P01AV37396. This 20-character code uniquely identifies Pharma Opportunity Fund in global financial transactions as per ISO 17442.

Is Pharma Opportunity Fund's LEI active? +

Yes, Pharma Opportunity Fund's LEI is currently active (registration status: LAPSED). The record was last updated on Aug 6, 2025 and is due for renewal on Aug 6, 2025.

Where is Pharma Opportunity Fund registered? +

Pharma Opportunity Fund is registered in Liechtenstein (jurisdiction: LI).

Who owns Pharma Opportunity Fund? +

According to GLEIF Level 2 relationship data, Pharma Opportunity Fund's parent entity is CAIAC Fund Management AG. This ownership information is based on accounting consolidation data reported to the Global LEI System.

What is a Legal Entity Identifier (LEI)? +

An LEI is a 20-character alphanumeric code based on the ISO 17442 standard. It connects to key reference information that enables clear and unique identification of legal entities participating in financial transactions. LEIs are issued by Local Operating Units (LOUs) accredited by the Global Legal Entity Identifier Foundation (GLEIF).

About This LEI Record

This page shows the Legal Entity Identifier (LEI) record for Pharma Opportunity Fund, registered in Liechtenstein. The LEI code 875500H0Q8P01AV37396 is a globally unique 20-character identifier assigned under the ISO 17442 standard to legal entities participating in financial transactions.

The reference data displayed above is sourced from the Global Legal Entity Identifier Foundation (GLEIF) and is updated hourly. This includes Level 1 data (entity identification and addresses) and Level 2 data (ownership relationships), where available.

If the registration status shows "Lapsed," it means the entity has not completed its annual renewal — the LEI still uniquely identifies this entity, but the reference data may not reflect the most recent information. For the most authoritative data, you can cross-reference this record on the official GLEIF website.